-------------------------
                                                      OMB APPROVAL
                                                      -------------------------
                                                      OMB Number:  3235-0145
                                                      Expires: October 31, 1994
                                                      Estimated average burden
                                                      hours per response...14.90
                                                      -------------------------


                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13G

                    Under the Securities Exchange Act of 1934

                               (Amendment No. 3)*

                           Inhale Therapeutic Systems
                           --------------------------
                                (Name of Issuer)

                           Common Stock, no par value
                         ------------------------------
                         (Title of Class of Securities)

                                    457191104
                                 --------------
                                 (CUSIP Number)

*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).





Item 1(a). Name of Issuer: Inhale Therapeutic Systems.

Item 1(b). Address of Issuer's Principal Executive Offices:
           1525 Industrial Way, Belmont, CA 94002.

Item 2(a). Names of Persons Filing: New Enterprise Associates V, Limited
           Partnership ("NEA V"), NEA Partners V, Limited Partnership ("NEA
           Partners V"), which is the sole general partner of NEA V, NEA
           ONSET Partners, Limited Partnership ("ONSET Partners") and
           Cornelius J. Bond, Jr. ("Bond"), Frank A. Bonsal, Jr. ("Bonsal"),
           Nancy L. Dorman ("Dorman"), C. Richard Kramlich ("Kramlich"), Arthur
           J. Marks ("Marks"), Thomas C. McConnell ("McConnell") and Charles W.
           Newhall III ("Newhall") (collectively, the "General Partners").
           Bonsal, Dorman, Kramlich, Marks, McConnell and Newhall are individual
           general partners of NEA Partners V. Bond, Bonsal, Dorman, Kramlich,
           Marks, McConnell and Newhall are individual general partners of ONSET
           Partners. The persons named in this paragraph are referred to
           individually herein as a "Reporting Person" and collectively as the
           "Reporting Persons."

Item 4.    Ownership.

           Not applicable.

Item 5.    Ownership of Five Percent or Less of a Class.

           Each Reporting Person has ceased to be the beneficial owner of more
           than five percent of outstanding Common Stock of Inhale Therapeutic
           Systems.

           All other items of this Schedule 13G remain the same as reported on
           the Schedule 13G dated as of February 10, 1997 and filed on behalf of
           the Reporting Persons with respect to the Common Stock of Inhale
           Therapeutic Systems, except to reflect that each of the Reporting
           Persons has ceased to be the beneficial owner of more than five
           percent of the Common Stock of Inhale Therapeutic Systems.


                               Page 2 of 6 Pages




                                    SIGNATURE

      After reasonable inquiry and to the best of its knowledge and belief, each
of the undersigned certifies that the information set forth in this statement is
true, complete and correct.

Date:  February 10, 1998


NEW ENTERPRISE ASSOCIATES V, LIMITED PARTNERSHIP

By: NEA PARTNERS V, LIMITED PARTNERSHIP

    By:             *
      _____________________________________
      Charles W. Newhall III
      General Partner


NEA PARTNERS V, LIMITED PARTNERSHIP

    By:             *
      _____________________________________
      Charles W. Newhall III
      General Partner


NEA ONSET Partners, Limited Partnership

    By:                 *
      _____________________________________
      Charles W. Newhall III
      General Partner


                    *
      ______________________________________
      Cornelius C. Bond, Jr.


                               Page 3 of 6 Pages




                    *
      ______________________________________
      Frank A. Bonsal, Jr.


                    *
      ______________________________________
      C. Richard Kramlich


                    *
      ______________________________________
      Arthur J. Marks


                    *
      ______________________________________
      Thomas C. McConnell


                    *
      ______________________________________
      Charles W. Newhall III



                                *By:  /s/ Nancy L. Dorman
                                      Nancy L. Dorman, in her individual
                                      capacity and as Attorney-in-Fact

________________________________________________________________________________

This Schedule 13G was executed by Nancy L. Dorman pursuant to Powers of Attorney
filed with the Securities and Exchange Commission on February 13, 1992 in
connection with a Schedule 13G for Advanced Interventional Systems Inc. and on
February 13, 1995 in connection with a Schedule 13G for Acuity Imaging, Inc.,
which Powers of Attorney are incorporated herein by reference.


                               Page 4 of 6 Pages





                                                                       Exhibit 1
                                                                       ---------

                                    AGREEMENT


      Pursuant to Rule 13d-1(f)(1) under the Securities Exchange Act of 1934,
the undersigned hereby agree that only one statement containing the information
required by Schedule 13G need be filed with respect to the ownership by each of
the undersigned of shares of Common Stock of Inhale Therapeutic Systems.

      EXECUTED as a sealed instrument this 10th day of February, 1998.


NEW ENTERPRISE ASSOCIATES V, LIMITED PARTNERSHIP

    By: NEA PARTNERS V, LIMITED PARTNERSHIP

    By:             *
      _____________________________________
      Charles W. Newhall III
      General Partner


    NEA PARTNERS V, LIMITED PARTNERSHIP

    By:             *
      _____________________________________
      Charles W. Newhall III
      General Partner


    NEA ONSET Partners, Limited Partnership

    By:                 *
    _______________________________________
    Charles W. Newhall III
    General Partner


                    *
    _______________________________________
    Cornelius C. Bond, Jr.

                               Page 5 of 6 Pages





                    *
    _______________________________________
    Frank A. Bonsal, Jr.


                    *
    _______________________________________
    C. Richard Kramlich


                    *
    _______________________________________
    Arthur J. Marks


                    *
    _______________________________________
    Thomas C. McConnell


                    *
    _______________________________________
    Charles W. Newhall III


                                         *By: /s/ Nancy L. Dorman
                                             ___________________________________
                                             Nancy L. Dorman, in her individual
                                             capacity and as Attorney-in-Fact

________________________________________________________________________________

This Agreement was executed by Nancy L. Dorman pursuant to Powers of Attorney
filed with the Securities and Exchange Commission on February 13, 1992 in
connection with a Schedule 13G for Advanced Interventional Systems Inc. and on
February 13, 1995 in connection with a Schedule 13G for Acuity Imaging, Inc.,
which Powers of Attorney are incorporated herein by reference.